Healthcare -
Biotechnology - NASDAQ - US
$ 14.52
-6.02 %
$ 1.1 B
Market Cap
-5.04
P/E
NRIX - CASH & EQUIVALENTS
Cash & Equivalents NRIX - Nurix Therapeutics, Inc.
110 M
LAST VALUE
30.62%
2 YEAR CAGR
25.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR